465 related articles for article (PubMed ID: 22972070)
21. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
Choi SH; Cesar A; Snow TAC; Saleem N; Arulkumaran N; Singer M
Int J Antimicrob Agents; 2023 Sep; 62(3):106905. PubMed ID: 37385561
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Empiric Antibiotic Treatment Regimens for Hospitalized, Non-severe Community-acquired Pneumonia: A Retrospective, Multicenter Cohort Study.
Reeves SD; Hartmann AP; Tedder AC; Juang PA; Hofer M; Kollef MH; Micek ST; Betthauser KD
Clin Ther; 2024 Apr; 46(4):338-344. PubMed ID: 38403509
[TBL] [Abstract][Full Text] [Related]
23. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis.
Asadi L; Sligl WI; Eurich DT; Colmers IN; Tjosvold L; Marrie TJ; Majumdar SR
Clin Infect Dis; 2012 Aug; 55(3):371-80. PubMed ID: 22511553
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic antibiotics for inhibiting preterm labour with intact membranes.
Flenady V; Hawley G; Stock OM; Kenyon S; Badawi N
Cochrane Database Syst Rev; 2013 Dec; (12):CD000246. PubMed ID: 24307518
[TBL] [Abstract][Full Text] [Related]
25. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
[TBL] [Abstract][Full Text] [Related]
26. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
Al Saeedy D; Gillani SW; Al-Salloum J; Moosvi A; Eissa M; Gulam SM
Curr Pediatr Rev; 2020; 16(4):307-313. PubMed ID: 32895041
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic treatment outcomes in community-acquired pneumonia.
Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
[TBL] [Abstract][Full Text] [Related]
28. β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis.
Nie W; Li B; Xiu Q
J Antimicrob Chemother; 2014 Jun; 69(6):1441-6. PubMed ID: 24535276
[TBL] [Abstract][Full Text] [Related]
29. Antibiotics for community acquired pneumonia in children.
Kabra SK; Lodha R; Pandey RM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004874. PubMed ID: 16856067
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of empiric macrolides versus fluoroquinolones in community-acquired pneumonia associated with atypical bacteria: A meta-analysis.
Basilim A; Wali H; Rabaan AA; Eljaaly K
Respir Med Res; 2022 Nov; 82():100931. PubMed ID: 35905552
[TBL] [Abstract][Full Text] [Related]
31. Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis.
Xu LY; Wang CC; Peng XX; Jiao Y; Zhao CZ; Zhang L; Ma L
J Glob Antimicrob Resist; 2022 Sep; 30():1-9. PubMed ID: 35643393
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.
Mills GD; Oehley MR; Arrol B
BMJ; 2005 Feb; 330(7489):456. PubMed ID: 15684024
[TBL] [Abstract][Full Text] [Related]
33. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
[TBL] [Abstract][Full Text] [Related]
34. Azithromycin for acute lower respiratory tract infections.
Laopaiboon M; Panpanich R; Swa Mya K
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001954. PubMed ID: 25749735
[TBL] [Abstract][Full Text] [Related]
35. Antibiotics for community-acquired pneumonia in children.
Kabra SK; Lodha R; Pandey RM
Cochrane Database Syst Rev; 2010 Mar; (3):CD004874. PubMed ID: 20238334
[TBL] [Abstract][Full Text] [Related]
36. Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis.
Liu S; Tong X; Ma Y; Wang D; Huang J; Zhang L; Wu M; Wang L; Liu T; Fan H
Front Pharmacol; 2019; 10():489. PubMed ID: 31139081
[No Abstract] [Full Text] [Related]
37. The dilemma of monotherapy or combination therapy in community-acquired pneumonia.
Vardakas KZ; Trigkidis KK; Apiranthiti KN; Falagas ME
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29027205
[TBL] [Abstract][Full Text] [Related]
38. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Mulholland S; Gavranich JB; Gillies MB; Chang AB
Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.
Gurusamy KS; Koti R; Wilson P; Davidson BR
Cochrane Database Syst Rev; 2013 Aug; (8):CD010268. PubMed ID: 23959704
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic prophylaxis for preventing burn wound infection.
Barajas-Nava LA; López-Alcalde J; Roqué i Figuls M; Solà I; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Jun; (6):CD008738. PubMed ID: 23740764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
